Peter L. Nara
Chief Executive Officer, President, Chairman & Co-founder
Biological Mimetics, Inc
USA
Biography
Dr. Nara is currently Chief Executive Officer, President, Chairman & co-founder of Biological Mimetics, Inc., a biotechnology company founded to translate the theory of “Deceptive Imprinting†and the “Immune Refocusing†Technology, discovered by Dr. Nara and colleagues, into preventative vaccines, novel immuno-therapeutics and diagnostics in both human and veterinary medicine. Prior to this position, Dr. Nara was formerly the Section Chief of the Vaccine Resistant Diseases Section, Division of Basic Sciences, Office of the Director at the National Cancer Institute, National Institutes of Health.
Research Interest
Immunobiotics for Human Oncology Drug for Drug Resistant Prostate, Ovarian, Pancreatic and Breast Cancer Prevention and Treatment of Heart Disease, Neuro-Cognitive Diseases (Dementia to Alzheimer’s), Diabetes, Osteoarthritis
Biography
Dr. Kwak is appointed Professor at Department of Pharmacology, Ajou University School of Medicine, Korea from 2015. He is currently the Director of Immune-network Pioneer Research Center, which is sponsored as one of the Pioneer Research Center Program by the Korean ministry of Science ICT & Future Planning. He is elected as Doctor Honoris Causa in Russian Academy of Science in 2012 and editorial boards in World J Exp Med and Advances in Modern Oncology Research. He contributed to editing special issue of Journal of Immunological Research 2014 entitled “Pathophysiological roles of cytokine-chemokine immune network†and is going to edit annual special issue. He has over 150 scientific papers and conducted over 10 invited presentations in international symposiums. He completed his doctorate in Medical Biochemistry with neutrophil activation and signal transduction pathways at the Pusan National University, Korea in 1991. After his study of phospholipase D activation of neutrophils in Emory University as a post doctorate, he joined the Department of Biochemistry at Dong-A University in 1997, where he directed his research to dendritic cell analysis.
Research Interest
Dendritic cell regulation Immunogenic response of cancer cells Chemokine network between dendritic cells and damaged cells 3D culture of immune cells
Biography
Noah Isakov is a Professor of Immunology and Chair of The Shraga Segal Department of Microbiology and Immunology at the Faculty of Health Sciences Ben Gurion University of the Negev Beer Sheva Israel. He received his PhD from the Weizmann Institute of Science in Rehovot Israel 1981 and performed postdoctoral studies at the University of Minnesota in Minneapolis MN 1981-1983 and the Scripps Research Institute in La Jolla CA 1983-1987. He performed a Sabbatical at the National Institute of Allergy and Infectious Diseases at the NIH Bethesda MD 1993-1995 and served as an Esther Z Greenberg Honors Chair in Biomedical Research at the Oklahoma Medical Research Foundation in Oklahoma City OK 2003-2004 and President of the Israel Immunological Society 2004-2006.
Research Interest
Immunology, signal transduction, tumor immunobiology